Skip to content
DraconiticResearch
Search Sources API
186,541 studies31 sourcesUpdated 29 min ago
Peer-reviewedCC BY-NC-NDBlood neoplasia

Combination therapy with nelarabine, pegaspargase, and venetoclax for adult patients with R/R T-cell ALL/LBL

  • Niranjan Khaire1
  • Elias Jabbour1
  • Tapan Kadia1
  • Nicholas Short1
  • Gautam Borthakur1
  • Naveen Pemmaraju1
  • Naval Daver1
  • Abhishek Maiti1
  • Partow Kebriaei2
  • Shilpa Paul1
  • Rebecca Garris1
  • Farhad Ravandi1
2 more authors
  • Hagop Kantarjian1
  • Nitin Jain1
  1. 1Department of Leukemia, The University of Texas MD Anderson Cancer Center, Houston, TX
  2. 2Department of Stem Cell Transplantation, The University of Texas MD Anderson Cancer Center, Houston, TX
Read full textPDFCite

Related

  1. Real‐World Survival Outcomes of Venetoclax Combination Therapies in Acute Myeloid Leukemia: Impact of Minimal Residual Disease Status and Antifungal Prophylaxis
    Mariarita Sciumè, Alessandro Bosi, Alfredo Marchetti +7
    Hematological oncologyPeer-reviewedCC BY-NC-NDFull textGeneral medicineEurope PMC
  2. Efficacy and safety of narlumosbart in combination with stereotactic body radiation therapy followed by first-line chemotherapy combined with immunotherapy in advanced driver gene-negative non-small cell lung cancer patients with bone metastases: a phase II, single-arm, single-centre clinical trial protocol
    Jin Li, Nianlan Zhou, Saiquan Lu +4
    BMJ OpenPeer-reviewedCC BY-NC 4.0Full textGeneral medicineCrossref
  3. Prolonged treatment-free remission after venetoclax in combination with a hypomethylating agent in acute myeloid leukemia with inv(16).
    Morgan L Shannon, Jared Wallace, Amy Kuo +1
    Annals of hematologyPeer-reviewedCC BY-NC-NDFull textGeneral medicineEurope PMCPMC
  4. FOLFOX plus nivolumab combination therapy for cisplatin-unfit patients with untreated advanced esophageal squamous cell carcinoma
    Nozomu Ogura, Shun Yamamoto, Ryuichi Morita +9
    EsophagusPeer-reviewedCC BY 4.0Full text2 citedSurgery & anaesthesiaPMC
  5. Infection Profiles Under Venetoclax‐Based Therapy in Newly Diagnosed Acute Myeloid Leukemia: A Real‐World Study
    Guilin Ren, Guangyu Zhou, Hao Zhou +8
    Cancer medicinePeer-reviewedCC BY-NCFull textGeneral medicineEurope PMC

Cite

BibTeXRIS
BibTeX
@article{khaire2026combination,
  title = {{Combination therapy with nelarabine, pegaspargase, and venetoclax for adult patients with R/R T-cell ALL/LBL}},
  author = {Niranjan Khaire and Elias Jabbour and Tapan Kadia and Nicholas Short and Gautam Borthakur and Naveen Pemmaraju and Naval Daver and Abhishek Maiti and Partow Kebriaei and Shilpa Paul and Rebecca Garris and Farhad Ravandi and Hagop Kantarjian and Nitin Jain},
  journal = {Blood neoplasia},
  year = {2026},
  month = sep,
  url = {https://europepmc.org/article/PMC/PMC13657215},
  note = {CC BY-NC-ND},
}
RIS
TY  - JOUR
TI  - Combination therapy with nelarabine, pegaspargase, and venetoclax for adult patients with R/R T-cell ALL/LBL
AU  - Niranjan Khaire
AU  - Elias Jabbour
AU  - Tapan Kadia
AU  - Nicholas Short
AU  - Gautam Borthakur
AU  - Naveen Pemmaraju
AU  - Naval Daver
AU  - Abhishek Maiti
AU  - Partow Kebriaei
AU  - Shilpa Paul
AU  - Rebecca Garris
AU  - Farhad Ravandi
AU  - Hagop Kantarjian
AU  - Nitin Jain
PY  - 2026
DA  - 2026/09/08
JO  - Blood neoplasia
UR  - https://europepmc.org/article/PMC/PMC13657215
SN  - 2950-3280
ER  -